ImmunityBio, Inc.IBRXNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
15.03%
↑ 172% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-20.85%
Historical baseline
PeriodValue
202515.03%
202429.09%
2023-40.00%
2022-20.12%
2021-56.32%
2020-237.22%
201931.63%
20180.20%
201720.19%
201649.00%